Belvedere Trading LLC Humanigen, Inc Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$1.76 - $3.33 $111,490 - $210,945	-63,347 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$1.81 - $3.97 $39,456 - $86,542	21,799 Added 52.47%	63,347 $145,000
Q2 2021 Jul 23, 2021	BUY	$13.54 - $22.74 $259,453 - $435,743	19,162 Added 85.6%	41,548 $710,000
Q1 2021 Apr 27, 2021	BUY	$12.91 - $23.83 $289,003 - $533,458	22,386 New	22,386 $428,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.